Author details

Full Name

Daniela Galimberti

Affiliation

ORCID

Career Start Year

1987

Papers

479

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35188955	Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia.	Brain	2023
36377606	Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia.	Alzheimers Dement	2023
37762203	Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies.		2023
37933893	Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.		2023
37933893	Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status.		2023
37834197	Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.		2023
37834197	Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.		2023
37643212	Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypes.	Proc Natl Acad Sci U S A	2023
37547746	Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic.		2023
37210544	Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease.		2023
36895129	Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia.	Hum Brain Mapp	2023
37393504	Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal Dementia.		2023
36812822	The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study.	J Neurol Sci	2023
37195665	Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease.	JAMA Netw Open	2023
36627201	Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales.	J Neurol Neurosurg Psychiatry	2023
36562783	Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.		2023
36562783	Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.		2023
37386003	Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation.		2023
37182885	Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.		2023
36938528	Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia.	Brain Commun	2023
37239970	TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease.		2023
36458975	Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers.	Brain	2023
37508992	A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia (MAINSTREAM): A Study Protocol.		2023
34806608	Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.	Journal of Alzheimer's Disease	2022
36245297	CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.	Ann Clin Transl Neurol	2022
35456950	Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration.	International Journal of Molecular Sciences	2022
35898720	Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of <i>C9orf72</i>.	Brain Commun	2022
36289929	A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's Disease.	Biomedicines	2022
35955622	miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia.	International Journal of Molecular Sciences	2022
35948443	Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia.	Neurology	2022
35884791	The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases.	Biomedicines	2022
35639372	Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.	JAMA Neurol	2022
35883623	Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer's Disease Patients.	Cells	2022
35379992	New insights into the genetic etiology of Alzheimer's disease and related dementias.	Nat Genet	2022
35379992	New insights into the genetic etiology of Alzheimer's disease and related dementias.	Nat Genet	2022
35563859	miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis.	Cells	2022
35563859	miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis.	Cells	2022
36140362	The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis.	Biomedicines	2022
35483895	Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.	Neurology	2022
36131298	Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia.	Acta neuropathologica communications	2022
36064515	Corrigendum to "Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study" [Neurobiology of Aging Volume 108, December 2021, Pages 155-167].	Neurobiol Aging	2022
35359635	Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.	Frontiers in Neurology	2022
36411364	Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.	Nat Genet	2022
36115967	Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation.	Alzheimer's Research and Therapy	2022
36115967	Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation.	Alzheimer's Research and Therapy	2022
35598462	Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis.	NeuroImage: Clinical	2022
35534236	Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis.	Neurology: Neuroimmunology and NeuroInflammation	2022
36499048	Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.		2022
36499048	Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.		2022
36698863	The expression pattern of GDF15 in human brain changes during aging and in Alzheimer's disease.		2022